Forecast: Diabetes Medicine Use in Spain

Between 2013 and 2023, the use of diabetes medicine in Spain significantly increased, as evidenced by an overall upward trend in the defined daily dosages per thousand persons per day. Starting at 66.6 units in 2013, the value grew to 90.5 units by 2023. Notable year-on-year variations include a peak increase of 6.76% in 2014, and an annual growth stabilization, especially between 2021 and 2023, with increases of 4.18%, 4.6%, and 2.14%, respectively. The last 5-year compound annual growth rate (CAGR) stood at 2.99% as of 2023.

Looking ahead, the forecast from 2024 to 2028 estimates a continued rise in diabetes medicine use, expecting to reach 100.9 units by 2028, with a forecast 5-year CAGR of 1.73%. The future trends to watch for include advancements in diabetes treatment, policy changes affecting medical access, and an aging population which might further drive the overall consumption of these medications.